This is the status of American healthcare companies in Russia following the February invasion of Ukraine:
Still operating:
Align Technology: Phoenix-based manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics
Amgen: biopharmaceutical company headquartered in Thousand Oaks, Calif.
Suspended some operations:
AmerisourceBergen: The Conshohocken, Pa.-based drug distribution and consulting company has ended all new business initiatives in Russia but will continue ongoing clinical trials and distribution of its health products.
Abbott Laboratories: The Abbott Park, Ill.-based medical manufacturer has suspended all nonessential business.
Eli Lilly: The Indianapolis-based pharmaceutical company has suspended all new investments and clinical trials.
Johnson & Johnson: The multinational pharmaceutical corporation headquartered in New Brunswick, N.J., has paused patient enrollment in ongoing trials.
AbbVie: The biopharmaceutical firm headquartered in North Chicago, Ill., has suspended aesthetics operations and paused all clinical trials.
Merck: The Kenilworth, N.J.-based pharmaceutical company will not make new investments or conduct clinical trial enrollments going forward.
Pfizer: The New York City-based pharmaceutical and biotechnology corporation will not make new investments or conduct new clinical trials going forward.
Suspended operations:
Conformis: The medical device manufacturer headquartered in Billerica, Mass., has suspended all distribution operations.
Mettler Toledo: The Columbus, Ohio-based medical laboratory device manufacturer has suspended all shipments.
SonoSim: The medical software developer headquartered in Santa Monica, Calif., has suspended its distributor relationships in Russia.
Thermo Fisher Scientific: The Waltham, Mass.-based medical equipment supplier has suspended all sales and manufacturing.
Waters Corp: The medical equipment manufacturer and software developer headquartered in Milford, Mass., has suspended all sales and services.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.